P38 mapk and radiotherapy: foes or friends?

HIGHLIGHTS

• who: Natalia Garcu00eda-Flores and collaborators from the Laboratorio Molecular, Unidad Medicina Molecular, Centro Regional Investigaciones, Unidad Asociada Biomedicina UCLM, Unidad Asociada al CSIC, Castilla-La Mancha, Albacete, Spain have published the research: P38 MAPK and Radiotherapy: Foes or Friends?, in the Journal: Cancers 2023, 15, 861. of 30/01/2023
• what: All evidence points to an important role for the p38 MAPK signaling pathway in the response to IR, with possible clinical implications in radiotherapy.
• future: The fact that p38 MAPK may be affecting radioresistance in irradiated tumor cells as well as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.